Recombinant Human AGR3 Protein，His

AGR3 (Anterior Gradient-3) is a protein that has garnered significant attention in recent years due to its potential roles in various biological processes, particularly in cancer biology. Initially identified as a developmentally regulated protein, AGR3 has been implicated in the progression of several tumors, including breast and colon cancers. It is believed to function as a co-chaperone in protein folding, assisting in the stabilization of client proteins, which may contribute to cancer cell survival and proliferation. Research has shown that AGR3 expression is often upregulated in cancerous tissues, correlating with increased tumor aggressiveness and poor patient prognosis. This has sparked interest in AGR3 as a potential biomarker for cancer diagnosis and prognosis, as well as a novel therapeutic target. Recent studies involving the recombinant expression of AGR3 protein have aimed to elucidate its structural properties and functional mechanisms, providing insights into its role in oncogenic processes. The ongoing investigation into AGR3's molecular pathways and interactions with other cellular components holds promise for developing targeted therapies and improving treatment outcomes for cancer patients. As a result, understanding the implications of AGR3 in various cancer types can lead to innovative approaches in cancer management and highlight the significance of this protein in the broader context of tumor biology.